Turner Christopher Durant
SEC insider (Form 3/4/5 filer). CIK 0001862146. Chief Medical Officer at Nuvalent, Inc. (NUVL). 16 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in CAMBRIDGE, MA.
Companies Turner Christopher Durant has filed insider reports for
- Nuvalent, Inc. (NUVL): Officer, Chief Medical Officer
Turner Christopher Durant
CIK: 0001862146
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)10 (62.5%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (18.8%)
Compensation grants
Other (G, F, J, C, D, …)3 (18.8%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NUVL
Nuvalent, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jul 15, 2026NUVL
Nuvalent, Inc.
Tender OfferDirect31.5K shares at avg. $124.00$3.9M - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionDirect41.1K shares- - Jul 15, 2026NUVL
Nuvalent, Inc.
AwardDirect14.4K shares- - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionDirect14.4K shares- - Jan 7, 2026NUVL
Nuvalent, Inc.
AwardDirect17.5K shares- - Jan 6, 2026NUVL
Nuvalent, Inc.
SaleDirect1.6K shares at avg. $97.33$159K - Jan 6, 2026NUVL
Nuvalent, Inc.
SaleDirect225 shares at avg. $98.40$22K - Jan 6, 2026NUVL
Nuvalent, Inc.
SaleDirect1.3K shares at avg. $96.75$128K - Jan 5, 2026NUVL
Nuvalent, Inc.
SaleDirect871 shares at avg. $96.06$84K - Jan 5, 2026NUVL
Nuvalent, Inc.
SaleDirect1.1K shares at avg. $96.85$108K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Tender Offer | 31,530 | $124.00 | $3,909,720 | Direct |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 41,100 | - | $0 | Direct |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Award | 14,350 | - | $0 | Direct |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 14,350 | - | $0 | Direct |
| Jan 7, 2026 | NUVL Nuvalent, Inc. | Award | 17,500 | - | $0 | Direct |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | Sale | 1,635 | $97.33 | $159,135 | Direct |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | Sale | 225 | $98.40 | $22,140 | Direct |
| Jan 6, 2026 | NUVL Nuvalent, Inc. | Sale | 1,321 | $96.75 | $127,807 | Direct |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | Sale | 871 | $96.06 | $83,668 | Direct |
| Jan 5, 2026 | NUVL Nuvalent, Inc. | Sale | 1,119 | $96.85 | $108,375 | Direct |
1-10 of 16 transactions